Pfizer: Undervalued Safe Haven In Risk-Off Market
Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...
Posts falsely claim Pfizer published list of Covid-19 vaccine side effects
Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...
Looking At Pfizer's Recent Unusual Options Activity
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is ...
Pfizer (NYSE:PFE) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility ...
Zacks Investment Research on MSN7d
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...
Pfizer: It's Time To Play Defensive
The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...
Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
Pfizer could use existing US manufacturing to counter potential tariff hit
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...